A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)

Clinical trial NCT01075282 · COMPLETED

Trial details

NCT number: NCT01075282
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-02-01
Primary completion: 2012-05-01
Enrollment: 810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.